Informations sur le produit
Erastin2 is a lipid-based gene therapy agent that is designed to inhibit the production of fatty acids. It binds with high affinity to enzymes involved in fatty acid synthesis and inhibits their activity, reducing the levels of fatty acid metabolites. Erastin2 has been shown to induce necrotic cell death in cancer cells and reduce body weight in obese mice. This drug has also been shown to induce autophagy, which is a process by which cells degrade themselves through apoptosis when nutrient availability is low. Erastin2 induces autophagy by activating AMPK (adenosine monophosphate kinase), which activates transcriptional regulation of genes involved in the autophagy pathway.
Propriétés chimiques
Question d’ordre technique sur : 3D-VSC53344 Erastin2
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
